Advertisement RWS Life Sciences - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

RWS Life Sciences

Logo
LATEST PRESS RELEASES
July 8, 2024

RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy

RWS working with other industry leaders to bridge gap between AI innovation and policy
pharmacuetical business review
June 26, 2024

RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award

Industry’s first linguistic-AI solution wins ‘ Machine Translation Innovation Award’
pharmacuetical business review


LATEST VIDEOS

RWS Life Sciences

RWS Life Sciences provides translation, content management and intellectual property services for the pharmaceutical and life sciences industries. We help customers connect with people worldwide by communicating content at scale, to enable the protection and realisation of ideas and innovations.

Our localisation, translation and transcreation services, alongside our translation management technology, machine translation and translation productivity tools, help companies reach global audiences.

Our solutions improve process efficiency, reduce translation costs, and help get products to market more quickly. You can create real value for your teams and ecosystem partners to drive better outcomes for scientists, medical representatives, professionals, and patients alike.

Accurate translations for clinical trials

Translations are an essential component of advancing clinical trials, and RWS’ knowledge of and focus on the life sciences industry allows us to handle any translation request with confidence.

Our clinical trial management services start with a thorough project analysis, letting us determine the most appropriate and customised translation solution for each request. Our procedures are flexible to allow us to deliver in the most timely and cost-effective manner.

We can translate a variety of documents, including protocols, case report forms (CRFs), protocol synopses, electronic clinical outcomes assessments (eCOAs), electronic patient-reported outcomes (ePROs), adverse event reports, patient records, and event logs.

Linguistic validation for clinical outcomes assessments

RWS is a trusted authority for the linguistic validation and management of clinical outcomes assessments (COAs). Whether the assessment is intended for a patient, clinician or observer, our translations are accurate and equivalent to the source instrument in cultural and conceptual terms.

Our linguistic validation process is modelled on the US Food and Drug Administration’s (FDA) patient-reported outcome (PRO) guidance document, as well as the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) good practice recommendations.

We have global relationships with translators, interviewers, instrument developers, survey research experts, clinicians and in-country reviewers, allowing us to run each validation project with ease and scientific accuracy.

Regulatory document translation capabilities

Patients’ safety relies on accurate pharmaceutical product information, so translating product materials accurately is a priority for RWS. Our industry specialisation, regulatory and terminology knowledge ensure accurate and timely translation.

All translations go through a set of clearly defined stages, including translation by two highly qualified linguists, multilingual multimedia production, an additional quality control edit, a final pre-production review and an in-country review, before they are certified.

Our translations adhere to methods required by global regulatory authorities, including the European Medicines Agency (EMA).

Pharmaceutical product documents we can translate include patient information leaflets (PILs), summaries of product characteristics (SmPCs), packaging inserts, pharmaceutical product information, regulatory correspondence, and patient prescription information.

Translation services for medical and in-vitro devices

RWS’s translation experts and linguists are committed to managing the unique nuances of medical and in-vitro device projects, including labelling, product manuals and patents.

Our ISO 13485-certified translation processes, routine risk assessment procedures, technology solutions and intelligent use of translation memory provides clients with the highest quality translations possible.

We can translate usage instructions, packaging inserts and labels, operating and installation manuals, patents, manufacturing procedures, regulatory compliance documents, data sheets and software applications among other documents.

About RWS Life Sciences

RWS’s translation experience and knowledge has been developed over more than six decades. Our smart technology, deep expertise and collective global intelligence take clients’ content and ideas to worldwide audiences.

We serve the technology, pharmaceutical, medical, financial services, legal, chemical, automotive, government and telecommunications sectors in Europe, Asia Pacific, North and South America.

Contact details

101 East River Drive,
East Hartford, CT 06108,
United States of America

Email: lifesciences@rws.com
Web: rws.com/industries/life-sciences
Phone: +1 860-727-6000

RWS Evolve — Superior, Efficient Translations for the Entire Translation Supply Chain

As the world's first genuine intelligence linguistic AI solution, RWS' Evolve allows pharmaceutical companies to harness the latest innovations in Generative AI in a fully secure, end-to-end Linguistic AI solution in a cost-efficient manner.

As the world's first genuine intelligence linguistic AI solution, RWS' Evolve allows pharmaceutical companies to harness the latest innovations in Generative AI in a fully secure, end-to-end Linguistic AI solution in a cost-efficient manner. The solution automating post-editing to minimise manual work and optimise expert resources in translation workflows, increasing productivity while maximising returns on…
Quick Contact RWS Life Sciences
Quick Contact RWS Life Sciences

RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy

RWS working with other industry leaders to bridge gap between AI innovation and policy
8th July 2024

RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award

Industry’s first linguistic-AI solution wins ‘ Machine Translation Innovation Award’
26th June 2024

Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions

Science-Based Targets initiative validates RWS’ commitment to reduce carbon emissions
18th June 2024

RWS at the 2023 CAHP Conference – 23-25 October in Palm Desert, California

RWS, a company providing translation services for pharmaceutical and life sciences companies, is exhibiting at the CAHP conference in Palm...
12th October 2023

RWS at ISOQOL 2023 – 18-21 October in Calgary, Canada

Life sciences-focused translation company RWS will be giving two presentations at this year’s International Society for Quality-of-Life Research (ISOQOL) conference....
5th October 2023

RWS at RAPS Convergence 2023 – 3-5 October in Montreal, Canada

RWS, a leading provider of translation services for pharmaceutical and life sciences companies, will be exhibiting at the RAPS Convergence trade fair...
28th September 2023

RWS Rated Best Translation Agency for 2023 by Business2Community

Global language translation company RWS has been ranked as the #1 translation agency by market consultant Business2Community. This is the...
4th August 2023

Continuing the Success Story

Gerresheimer, an innovative system and solution provider and global partner for the pharma and biotech industry, is dedicating even more...
3rd August 2023

Join Us at DIA Europe 2023 – 22-24 March in Basel, Switzerland

For 35 years now, DIA EUROPE is the largest neutral event in the European life science industry – the knowledge...
17th March 2023

RWS to Showcase Solutions During ISPOR EU

RWS is to take part in ISPOR, which is to take place between 6-9 November in Vienna, Austria.
28th October 2022

RWS at DIA 2022 in Chicago, Illinois, 19-23 June

RWS is excited to be speaking and exhibiting at DIA 2022 in Chicago, Illinois, alongside many other life sciences companies...
31st May 2022

RWS Holdings Announces Acquisition of Leading Document Authoring Platform, Fonto

RWS Holdings, a recognised leader in structured and web content management technology, has acquired Liones Holding (Fonto) to fuel innovation...
23rd March 2022
Quick Contact RWS Life Sciences


Quick Contact RWS Life Sciences
Quick Contact RWS Life Sciences
Quick Contact RWS Life Sciences


Contact RWS Life Sciences

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact RWS Life Sciences